Clinical Trials Directory

Trials / Unknown

UnknownNCT04123600

Origin Stem and Logical Cup Post Market Clinical Follow-up

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Signature Orthopaedics · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to monitor the performance of the Signature Orthopaedics Origin Stem and Logical Acetabular Cup as part of post-market vigilance and continuous improvement efforts.

Detailed description

The objective of this PMCF study is to collect data confirming safety, performance and clinical benefits of the Origin Stem and Logical Cup when used for primary total hip arthroplasty at 2 years follow-up. This prospective follow-up series is necessary to obtain data specific to the Origin Stem and Logical Cup considering their relatively recent launch to the market. The study includes pre-operative, operative, discharge, 1 year post-operative and 2 year post-operative evaluations, where data concerning the performance and safety of the device are gathered. In particular, the revision rate of the components will be monitored as the primary objective, along with pre- and post-operative measurement of the Oxford Hip Score (OHS) patient-reported outcome measure (PROM) to quantify patient satisfaction, and radiographic analysis to monitor bony response to the implant and qualify the effectiveness of the cementless fixation.

Conditions

Interventions

TypeNameDescription
DEVICEOrigin Stem and Logical CupThe Origin Stem is a straight, tapered, HA coated cementless femoral stem, and the Logical Cup is a porous coated acetabular cup mated with a cross-linked polyethylene liner. The components are used as part of a total joint replacement prosthesis.

Timeline

Start date
2019-11-19
Primary completion
2023-11-19
Completion
2023-11-19
First posted
2019-10-11
Last updated
2021-09-22

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04123600. Inclusion in this directory is not an endorsement.